Quita Highsmith, Genentech chief diversity officer (Credit: Genentech)
Genentech paves path to increased clinical trial diversity as a ‘business imperative’
Genentech is aiming to lead the charge for clinical trial diversity in the pharma industry and it’s using a mix of regulatory commitments, trial site …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
